ACRRM is seeking a representative for the Project Steering Committee for the Quality use of non-invasive prenatal RhD testing Project.
The Australian and New Zealand Society of Blood Transfusion (ANZSBT) is commencing this government-funded project, with the aim being to achieve a nationally available, standardised and optimised clinical RhD testing pathway to meet the needs of pregnant women and the general practitioners, obstetricians, midwives, pathologists involved in their care.
Committee members should ideally have relevant experience and interest in the management of RhD negative women and/or provision of RhD immunoglobulin for prophylaxis. The project will run for approximately 15 months and membership of the steering committee will require a regular commitment including attendance at online monthly meetings and a willingness to provide occasional advice to the project.
If you would like to nominate for this role or if you would like a copy of the terms of reference, please contact Juleen Schneider on j.schneider@acrrm.org.au. Nominations are due by Tuesday 9 August 2022.
The Australian and New Zealand Society of Blood Transfusion (ANZSBT) is commencing this government-funded project, with the aim being to achieve a nationally available, standardised and optimised clinical RhD testing pathway to meet the needs of pregnant women and the general practitioners, obstetricians, midwives, pathologists involved in their care.
Committee members should ideally have relevant experience and interest in the management of RhD negative women and/or provision of RhD immunoglobulin for prophylaxis. The project will run for approximately 15 months and membership of the steering committee will require a regular commitment including attendance at online monthly meetings and a willingness to provide occasional advice to the project.
If you would like to nominate for this role or if you would like a copy of the terms of reference, please contact Juleen Schneider on j.schneider@acrrm.org.au. Nominations are due by Tuesday 9 August 2022.